Cancer
KEYNOTE-590 Trial: Pembrolizumab Improves OS in Esophageal Cancer
… predicted investigator Peter C. Enzinger, MD, the director of Dana-Farber Cancer Institute's Center for Esophageal and Gastric Cancer, in Boston.
… predicted investigator Peter C. Enzinger, MD, the director of Dana-Farber Cancer Institute's Center for Esophageal and Gastric Cancer, in Boston.
